P043 Small intestinal inflammation but not colitis drives pro-inflammatory nutritional antigen-specific T-cell response
ECCO'20 Vienna
2020
P045 Profiling of human circulating dendritic cells and monocytes subsets discriminates type and mucosal status in patients with inflammatory bowel disease
ECCO'20 Vienna
2020
P046 Vitamin D decreases PDIA3 and prevents the enhanced migration of fibroblasts from stricturing Crohn’s disease
ECCO'20 Vienna
2020
P047 Differences in extra cellular matrix remodelling in highly active Crohn’s disease and ulcerative colitis
ECCO'20 Vienna
2020
P048 Mucosal macrophages express elevated levels of HDAC9 in inflamed and uninflamed mucosa of Crohn’s disease, but not ulcerative colitis
ECCO'20 Vienna
2020
P050 Analysis of 61 exclusive enteral nutrition formulas used for induction of remission in Crohn’s disease: new insights on dietary disease triggers
ECCO'20 Vienna
2020
P052 Nuclear magnetic resonance metabolomic profiling of IBD patients under anti-TNF treatment. Are the pathways network deregulated?
ECCO'20 Vienna
2020
P053 3-Oxo-C12:2, a quorum sensing molecule from the human gut, exerts anti-inflammatory effects through a bitter taste receptor
ECCO'20 Vienna
2020
P054 The impact of intestinal stenosis on the expression of Crohn’s disease in young mice with genetic predisposition
ECCO'20 Vienna
2020
P055 Effect of Mimosa caesalpiniifolia extract on DSS-induced colitis in Wistar rats
ECCO'20 Vienna
2020
P056 Kefir (Lactobacillus kefiranofaciens) promotes autophagy and protects the intestinal barrier against DSS-induced colitis
ECCO'20 Vienna
2020
P057 IL-17 regulates expression of chemotactic chemokines in human colonic subepithelial myofibroblasts
ECCO'20 Vienna
2020
P060 The pharmacologic inhibition of store-operated calcium entry pathway in inflammatory bowel disease
ECCO'20 Vienna
2020